Can a tablet replace the Doctor's office for memory tests?

NCT ID NCT07664865

Completed Diagnosis Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a tablet-based platform called Tenèpsia® for remote cognitive assessments in 250 healthy adults and people with cognitive impairment. The goal was to collect normal test scores and validate the digital tool for diagnosing neurocognitive disorders. If proven reliable, it could make cognitive testing more accessible, especially for those who have trouble traveling to clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tenèpsia® tablet-based teleneuropsychological platform
What this could lead to: If successful, this could provide a reliable, remote way to assess cognitive decline, making diagnosis more accessible for older adults with mobility issues or in rural areas.
What could go wrong: This is a validation study, not a treatment trial. It focuses on standardizing the digital test, not on improving health outcomes. Results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction dementia neurodegenerative disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE IMPAIRMENT

Contacts and locations

Locations

Unit of Research in Cognitive Psychology

Pavia, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.